| A translational pharmacology approach to understanding the predictive value of abuse potential assessments DB Horton, DM Potter, AN Mead Behavioural pharmacology 24 (5 and 6), 410-436, 2013 | 51 | 2013 |
| Acknowledgment of reviewers forVolume 14 J Andrews, UK Newhouse, J Arnt, C Baunez, C Belzung, F Borsini, ... Behavioural Pharmacology 14 (8), 653, 2003 | | 2003 |
| Altschuld, RA, 1 Argyropoulos, SV, 197, 213 AvendaoÄ, C., 15 H Awad, F Chang, G Cirino, L Cohn, PJ Conn, W Davidson, G Emilien, ... Pharmacology & Therapeutics 88, 465, 2000 | | 2000 |
| AMPA involvement in c-fos expression in prefrontal cortex and amygdala dissociates neural substrates of conditioned activity and conditioned reward AN Mead, A Vasilaki, C Spyraki, D Duka, DN Stephens University of Sussex, 0 | | |
| AMPA receptor GluR2, but not GluR1, subunit deletion impairs emotional response conditioning in mice. AN Mead, HV Morris, CI Dixon, SL Rulten, LV Mayne, D Zamanillo, ... Behavioral neuroscience 120 (2), 241, 2006 | 32 | 2006 |
| AMPA receptors and motivation for drug: effect of the selective antagonist NBQX on behavioural sensitization and on self-administration in mice A Jackson, AN Mead, BA Rocha, DN Stephens Behavioural pharmacology 9 (5), 457-467, 1998 | 42 | 1998 |
| AMPA-receptor GluR1 subunits are involved in the control over behavior by cocaine-paired cues AN Mead, D Zamanillo, N Becker, DN Stephens Neuropsychopharmacology 32 (2), 343-353, 2007 | 62 | 2007 |
| AMPA-receptors are involved in the expression of amphetamine-induced behavioural sensitisation, but not in the expression of amphetamine-induced conditioned activity in mice AN Mead, DN Stephens Neuropharmacology 37 (9), 1131-1138, 1998 | 51 | 1998 |
| AMPA‐receptor involvement in c‐fos expression in the medial prefrontal cortex and amygdala dissociates neural substrates of conditioned activity and conditioned reward AN Mead, A Vasilaki, C Spyraki, T Duka, DN Stephens European Journal of Neuroscience 11 (11), 4089-4098, 1999 | 73 | 1999 |
| Analysis of concordance of nonclinical rodent respiratory function measurements to phase i trial outcome using the animal model framework L Ewart, H Amouzadeh, M Aylott, K Chapman, P Jordaan, D Leishman, ... Journal of Pharmacological and Toxicological Methods 1 (68), e42-e43, 2013 | 1 | 2013 |
| Appropriate experimental approaches for predicting abuse potential and addictive qualities in preclinical drug discovery AN Mead Expert Opinion on Drug Discovery 9 (11), 1281-1291, 2014 | 13 | 2014 |
| Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials AN Mead, HR Amouzadeh, K Chapman, L Ewart, A Giarola, SJ Jackson, ... Regulatory Toxicology and Pharmacology 80, 348-357, 2016 | 59 | 2016 |
| BEHAVIORAL/SYSTEMS/COGNITIVE-Involvement of AMPA Receptor GluR2 Subunits in Stimulus-Reward Learning: Evidence from Glutamate Receptor gria2 Knock-Out Mice AN Mead, DN Stephens Journal of Neuroscience 23 (29), 9500-9507, 2003 | | 2003 |
| Behavioural effects of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to substance abuse A Jackson, AN Mead, DN Stephens University of Sussex, 0 | | |
| Behavioural effects of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to substance abuse A Jackson, AN Mead, DN Stephens Pharmacology & therapeutics 88 (1), 59-76, 2000 | 44 | 2000 |
| Behavioural plasticity-induced changes in drug response. Commentary on Badiani and Robinson drug-induced neurobehavioral plasticity: the role of environmental context DN Stephens, AN Mead Behavioural pharmacology 15 (5), 377-380, 2004 | 3 | 2004 |
| Blockade of the expression of a place preference conditioned to amphetamine by an antagonist of the strynine-insensitive glycine site of the NMDA receptor but not by an AMPA … AN Mead, DN Stephens University of Sussex, 1999 | 2 | 1999 |
| Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior TT Wager, RY Chandrasekaran, J Bradley, D Rubitski, H Berke, S Mente, ... ACS Chemical Neuroscience 5 (12), 1253-1265, 2014 | 38 | 2014 |
| Casein kinase-1 inhibitors as a novel treatment for substance use disorders DB Horton, E Dunn-Sims, TT Wager, C Chang, A Doran, A Rosado, ... Drug and Alcohol Dependence 100 (156), e98, 2015 | | 2015 |
| Characterisation of pentobarbital physical dependence and withdrawal in rats DI Coles, A Broad, A Mead Journal of Pharmacological and Toxicological Methods 2 (62), e9, 2010 | 1 | 2010 |
